Questions and Approaches to the Choice of Surgical Treatment of the Differentiated Thyroid Cancer

Article Sidebar

PDF (Українська)
Published: Oct 1, 2013
DOI: https://doi.org/10.22141/2224-0721.7.55.2013.84683
Keywords:
differentiated thyroid cancer, papillary carcinoma, follicular carcinoma

Main Article Content

I.R. Yanchiy
State Institution «Institute of Endocrinology and Metabolism named after V.P. Komisarenko of the National Academy of Medical Sciences of Ukraine», Kyiv, Ukraine
M.Yu. Bolgov
State Institution «Institute of Endocrinology and Metabolism named after V.P. Komisarenko of the National Academy of Medical Sciences of Ukraine», Kyiv, Ukraine

Abstract

The differentiated thyroid carcinomas (papillary and follicular) are characterized by very favorable prognosis — the survival of patients exceeds 90 %. At the same time, tactics of their treatment is rather aggressive — radical removal of all thyroid gland, often added by a lymph nodes dissection, with the subsequent ablation of residual thyroid tissue. Efficiency of such approach is caused by the good follow-up results: low level of recurrence, long terms of a survival of patients, opportunity to carry out monitoring of patients by thyroglobuline level in blood and in due time to reveal and destroy metastases by radioactive iodine. However, today many surgeons prove possibility of carrying out organ-preserving surgery at the low-invasive differentiated forms of a thyroid cancer. This problem is extremely actually for Ukraine as the incidence of the differentiated thyroid cancer in group of high risk (those who were children and adolescents at the moment of the Chernobyl accident) remains still high. Thus, on the one hand, the fact of radiation exposure in the history of the patient is the accurate indication to a radical thyroidectomy with the subsequent radio iodide ablation. However, on the other hand, with growing-up of patients and moving from the date of the accident, there is increasing the percentage of carcinomas with a low potential of aggressiveness — microcarcinomas and the encapsulated tumors. In this regard carrying out the careful analysis of all cases of «post-Chernobyl» thyroid carcinomas in which organ-preserving surgery was performed, and patients categorically refused from repeated surgical intervention, is very actual. Probably, exactly such researches will make it possible to change reasonably in the future the tactics of surgical treatment of potentially radio-induced thyroid carcinomas.

Article Details

How to Cite
Yanchiy, I., and M. Bolgov. “Questions and Approaches to the Choice of Surgical Treatment of the Differentiated Thyroid Cancer”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), no. 7.55, Oct. 2013, pp. 69-81, doi:10.22141/2224-0721.7.55.2013.84683.
Issue
No. 7.55 (2013)
Section
Literature Review
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our edition uses the copyright terms of Creative Commons for open access journals.

Authors, who are published in this journal, agree with the following terms:

  1. The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
  2. Directing  the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
  3. The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
  4. The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
  5. The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
  6. The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.

References

Богданова Т.І., Зурнаджи Л.Ю. Морфологічна характеристика карцином щитовидної залози дітей і підлітків України, постраждалих внаслідок Чорнобильської катастрофи // Ендокринологія. — 2006. — Т. 11, № 1. — С. 93-108.

Богданова Т.И., Козырицкий В.Г., Тронько Н.Д. Патология щитовидной железы у детей (Атлас). — К.: Чернобыль-интеринформ, 2000. — 160 с.

Болгов М.Ю. Віддалені результати органозберігаючих операцій при високодиференційованих карциномах щитоподібної залози // Ендокринологія. — 2009. — Т. 14, № 1. — С. 21-26.

Божок Ю.М., Зелінська Г.В., Хоруженко А.І. Шляхи вдосконалення доопераційної діагностики карцином щитовидної залози на основі вивчення змін адгезивності клітин при малігнізації // Журнал АМН України. — 1999. — № 2. — P. 344-351.

Ванушко В.Э., Цуркан А.Ю. Лечение дифференцированного рака щитовидной железы: состояние проблемы // Клин. эксп. тиреоид. — 2010. — Т. 6, № 2. — С. 24-33.

Воскобойник Л.Г., Богданова Т.І., Зурнаджи Л.Ю., Дегтярьова Т.Л. Оцінка ефективності використання експрес-гістологічних та цитологічних методів в інтраопераційній діагностиці новоутворень щитовидної залози // Ендокринологія. — 2009. — Т. 14, № 1. — С. 4-13.

Воскобойник Л.Г., Гулий Т.В. Может ли сопутствующая тиреоидная патология влиять на фенотип карцином щитовидной железы // Журнал НАМН Украины. — 2013. — Т. 19, № 1. — С. 46-56.

Гульчій М.В. Клінічні особливості перебігу раку щитоподібної залози у поєднанні з іншою тиреоїдною патологією та без неї // Ліки України. — 2007. — № 11. — С. 81-85.

Зурнаджи Л.Ю. Папілярна карцинома щитовидної залози: морфологічна характеристика в різні періоди після Чорнобильської катастрофи: Автореф. дис... канд. мед. наук. — К., 2009. — 24 с.

Коваленко А.Є., Омельчук О.В., Зиныч П.П. та ін. Хірургічне лікування папілярного раку щитоподібної залози у дітей і підлітків // Клінічна хірургія. — 2008. — № 4–5. — С. 71-73.

Комиссаренко И.В., Рыбаков С.И., Коваленко А.Е. Хирургическое лечение рака щитовидной железы // Клиническая хирургия. — 1993. — № 12. — C. 40-43.

Комиссаренко И.В., Рыбаков С.Й., Коваленко А.Е. Выполнение органосохраняющих операций по поводу высокодифференцированного рака щитовидной железы у детей // Клиническая хирургия. — 1999. — № 1. — С. 27-30.

Люткевич О.В. Особливості тактики і вибір методу хірургічного лікування злоякісних пухлин щитоподібної залози в період після аварії на Чорнобильській АЕС: Автореф. дис... канд. мед. наук. — К., 2007. — 21 с.

Мельниченко Г.А. и др. Спорные вопросы лечения дифференцированного рака щитовидной железы // Пробл. эндокринол. — 2008. — Т. 54, № 2. — С. 14-22.

Пачес А.И., Пропп Р.М. Рак щитовидной железы. — М., 1984. — 319 с.

Романчишин А.Ф. Хирургия щитовидной и околощитовидных желез. — СПб.: ИПК «Вести», 2009. — 647 с.

Романчишин А.Ф., Колосюк В.А., Багатурия Г.О. Рак щитовидной железы — проблемы эпидемиологии, этиопатогенеза и лечения. — СПб.: Издательство «Welcome», 2003. — 256 с.

Румянцев П.О., Ильин А.А., Румянцева У.В., Саенко В.А. Рак щитовидной железы: современные подходы к диагностике и лечению (Библиотека врача-специалиста). — М.: ГОЭТАР-Медиа, 2009. — 448 с.

Рыбаков С.И. Рак щитовидной железы: клинические лекции. — Полтава: ООО «АСМИ», 2012. — 572 с.

Тронько Н.Д., Богданова Т.И. Рак щитовидной железы у детей Украины (последствия Чернобыльской катастрофы). — К.: Чернобыльинтеринформ, 1997. — 200 с.

Тронько М.Д., Богданова Т.І. Рак щитовидної залози у дітей та підлітків України після аварії на Чорнобильській АЕС (епідеміологія, клінічні, патоморфологічні та молекулярно-генетичні аспекти) // Журнал НАМН України. — 2011. — Т. 17, № 2. — С. 139-143.

Чернишов С.В. Регіонарне лімфогенне метастазування папілярних карцином щитоподібної залози дітей та підлітків: клінічна характеристика, діагностика та хірургічне лікування: Автореф. дис... канд. мед. наук. — 2009. — 24 с.

Ahn D., Heo S.J., Park J.H. et al. Clinical relationship between Hashimoto’s thyroiditis and papillary thyroid cancer // Acta Oncol. — 2011. — Vol. 50, № 8. — P. 1228-1234.

Aliyev A., Ylmaz S., Ozhan M. et al. FDG PET/CT in the detection of metastases in a patient with Tg and 131I WBS negative follicular thyroid cancer // Clin. Nucl. Med. — 2013. — Vol. 38, № 3. — P. 226-227.

Al-Shraim M.M., Hussein M.R., Musalam A.O. et al. Hurthle cell neoplasms of thyroid in south-western region of Saudi Arabia // West. Afr. J. Med. — 2010. — Vol. 29, № 6. — P. 398-402.

Antic T., Taxy J.B. Thyroid frozen section: supplementary or unnecessary? // Am. J. Surg. Pathol. — 2013. — Vol. 37, № 2. — Р. 282-286.

Ardito G., Revelli L., Giustozzi E. et al. Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy // Clin. Nucl. Med. — 2013. — Vol. 38, № 1. — P. 25-28.

Aschebrook-Kilfoy B., Kaplan E.L., Chiu B.C. et al. The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States // Ann. Surg. Oncol. — 2013. — (on-line).

Baloch Z.W., Shafique K., Flannagan M., Livolsi V.A. Encapsulated classic and follicular variants of papillary thyroid carcinoma: comparative clinicopathologic study // Endocr. Pract. — 2010. — Vol. 16, № 6. — P. 952-959.

Bose S., Walts A.E. Thyroid fine needle aspirate: a post-Bethesda update // Adv. Anat. Pathol. — 2012. — Vol. 19, № 3. — P. 160-169.

Botrugno I., Lovisetto F., Cobianchi L. et al. Incidental carcinoma in multinodular goiter: risk factors // Am. Surg. — 2011. — Vol. 77, № 11. — P. 1553-1558.

Boucek J., Kastner J., Skrivan J. et al. Occult thyroid carcinoma // Acta Otorhinolaryngol. Ital. — 2009. — Vol. 29, № 6. — P. 296-304.

Brownlie B.J., Turner J., Abdelaal A.S. Deaths due to differentiated thyroid cancer: a South Island, New Zealand experience: 1984–2009 // N. Z. Med. J. — 2012. — Vol. 125. —

P. 13-21.

Chukudebelu O., Dias A., Timon C. Changing trends in thyroidectomy // Ir. Med. J. — 2012. — Vol. 105, № 6. — P. 167-179.

Cooper D.S., Doherty G.M., Haugen B.R. et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer // Thyroid. — 2006. — Vol. 16, № 2. — P. 109-142.

Costamagna D., Pagano L., Caputo M. et al. Incidental cancer in patients surgically treated for benign thyroid disease. Our experience at a single institution // G. Chir. — 2013. — Vol. 34, № 1–2. — P. 21-26.

Cross G.A., Suarez H., Pitoia F. et al. Fatal outcome of a young woman with papillary thyroid carcinoma and Graves’ disease: possible implication of «cross-signalling» mechanism // Arq. Bras. Endocrinol. Metabol. — 2008. — Vol. 52, № 7. — P. 1194-1200.

Dal Maso L., Bosetti C., La Vecchia C., Franceschi S. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors // Cancer Causes Control. — 2009. — Vol. 20, № 1. — P. 75-86.

Davies L., Welch H.G. Thyroid cancer survival in the United States: observational data from 1973 to 2005 // Arch. Otolaryngol. Head Neck Surg. — 2010. — Vol. 136, № 5. — P. 440-444.

DeGroot L.J., Kaplan E.L., McCormick M., Straus F.H. Natural history, treatment, and course of papillary thyroid carcinoma // J. Clin. Endocrinol. Metab. — 1990. — Vol. 71, № 2. — P. 414-424.

DeLelis R., Lloyd R., Heitz Ph., Eng Ch. Pathology and genetics of tumours of endocrine organs. WHO classification of tumours. — Lyon: IARC Press, 2004. — 320 p.

Del Rio P., Cataldo S., Nizzoli R. et al. Preoperative diagnosis of thyroid follicular lesion: malignant postoperative ratio // Minerva Chir. — 2012. — Vol. 67, № 5. — P. 429-432.

Dralle H., Machens A. Primary surgery for differentiated thyroid cancer in the new millennium // J. Endocrinol. Invest. — 2012. — Vol. 35, № 6. — P. 10-15.

Dralle H., Musholt T.J., Schabram J. et al. German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors // Langenbecks Arch. Surg. — 2013. — Vol. 398, № 3. — P. 347-375.

Durante C., Montesano T., Torlontano M. et al. Papillary thyroid cancer: time course of recurrences during postsurgery surveillance // J. Clin. Endocrinol. Metab. — 2013. — Vol. 98, № 2. — P. 636-642.

Eastman C.J. Screening for thyroid disease and iodine deficiency // Pathology. — 2012. — Vol. 44, № 2. — P. 153-159.

Ellison L.F., Wilkins K. Canadian trends in cancer prevalence // Health Rep. — 2012. — Vol. 23, № 1. —

P. 7-16.

Enyioha C., Roman S.A., Sosa J.A. Central lymph node dissection in patients with papillary thyroid cancer: a population level analysis of 14,257 cases // Am. J. Surg. — 2013. —

(in press).

Faggiano A., Del Prete M., Marciello F. et al. Thyroid diseases in elderly // Minerva Endocrinol. — 2011. — Vol. 36, № 3. — P. 211-231.

Furukawa K., Preston D., Funamoto S. et al. Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure // Int. J. Cancer. — 2013. — Vol. 132, № 5. — P. 1222-1226.

Gharib H., Papini E., Valcavi R. et al. AACE/AME American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules // Endocr. Pract. — 2006. — Vol. 12, № 1. — P. 63-102.

Gharib H., Papini E., Paschke R. et al. AACE/AME/ETA American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules // J. Endocrinol. Invest. — 2010. — Vol. 33, № 5 (Suppl). — P. 1-50.

Goffredo P., Cheung K., Roman S.A., Sosa J.A. Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients // Ann. Surg. Oncol. — 2013. — Vol. 3. — P. 767-772.

Goffredo P., Roman S.A., Sosa J.A. Hurthle cell carcinoma: a population-level analysis of 3311 patients // Cancer. — 2013. — Vol. 119, № 3. — P. 504-511.

Gul K., Di Koc A., Ki-Yak G. et al. Thyroid carcinoma risk in patients with hyperthyroidism and role of preoperative cytology in diagnosis // Minerva Endocrinol. — 2009. — Vol. 34, № 4. — P. 281-288.

Hatch V., Brenner A., Bogdanova T. et al. A screening study of thyroid cancer and other thyroid diseases among individuals exposed in utero to iodine-131 from Chernobyl fallout // J. Clin. Endocrinol. Metab. — 2009. — Vol. 94, № 3. — P. 899-906.

Hassanain M., Wexler M. Conservative management of well-differentiated thyroid cancer // Can. J. Surg. — 2010. — Vol. 53, № 2. — P. 109-118.

Hay I., Grant C., Van Heerden J. et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period // Surgery. — 2008. — Vol. 144. — P. 980-988.

He Q., Zhuang D., Zheng L. et al. The surgical management of papillary thyroid microcarcinoma: a 162-month single-center experience of 273 cases // Am. Surg. — 2012. — Vol. 78, № 11. — P. 1215-1218.

Hegedus L. Clinical practice. The thyroid nodule // New Engl. J. Med. — 2004. — Vol. 351. — P. 1764-1771.

Hodgson N.C., Button J., Solorzano C.C. Thyroid cancer: is the incidence still increasing? // Ann. Surg. Oncol. — 2004. — Vol. 11. — Р. 1093-1097.

How J., Tabah R. Explaining the increasing incidence of differentiated thyroid cancer // CMAJ. — 2007. — Vol. 177, № 11. — P. 1383-1394.

Huang B.Y., Hseuh C., Chao T.C. et al. Well-differentiated thyroid carcinoma with concomitant Hashimoto’s thyroiditis present with less aggressive clinical stage and low recurrence // Endocr. Pathol. — 2011. — Vol. 22, № 3. — P. 144-149.

Ivanov V.K., Chekin S.Y., Kashcheev V.V. et al. Risk of thyroid cancer among Chernobyl emergency workers of Russia// Radiat. Environ. Biophys. — 2008. — Vol. 47, № 4. — P. 463-467.

Jacob P., Bogdanova T.I., Buglova E. et al. Thyroid cancer among Ukrainian and Belarusians who were children or adolescents at the time of the Chernobyl accident // J. Radiol. Protec. — 2006. — Vol. 26. — P. 51-67.

Jemal A., Bray F., Center M.M. et al. Global cancer statistics // CA Cancer J. Clin. — 2011. — Vol. 61, № 2. — P. 69-90.

Jeong J.S., Kim H.K., Lee C.R. et al. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome // J. Korean Med. Sci. — 2012. — Vol. 27, № 8. — P. 883-889.

Kachuri L., De P., Ellison L.F., Semenciw R. Cancer incidence, mortality and survival trends in Canada,1970–2007 // Chronic. Dis. Inj. Can. — 2013. — Vol. 33, № 2. — P. 69-80.

Karagulle E., Yildirim S., Karakayali F. et al. Malignancy rates in operated patients with hyperthyroidism in an area of endemic goiter // Int. Surg. — 2009. — Vol. 94, № 4. — P. 325-329.

Kikuchi S., Perrier N.D., Ituarte Ph. et al. Latency period of thyroid neoplasia after radiation exposure // Ann. Surg. — 2004. — Vol. 239. — P. 536-543.

Kim E.Y., Kim W.G., Kim W.B. et al. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma // Clin. Endocrinol. — 2009. — Vol. 71. — P. 581-586.

Kim S.S., Kim S.J., Kim I.J. et al. Comparison of clinical outcomes in differentiated thyroid carcinoma between children and young adult patients // Clin. Nucl. Med. — 2012. — Vol. 37, № 9. — P. 850-853.

Kirillov V., Emeliyanova O. Differential diagnosis of follicular tumor by expert systems based on a set of quantitative features of thyrocyte nuclei and aggregates // Anal. Quant. Cytol. Histol. — 2012. — Vol. 34, № 2. — P. 86-95.

Kobayashi S. Appropriate extent of lymph node dissection in thyroid cancer // Nippon Geka Gakkai Zasshi. — 2001. — Vol. 102, № 6. — P. 459-464.

Kumagai A., Yamashita S. Risk of thyroid cancer occurrence by nuclear disasters and its countermeasures // Nihon. Rinsho. — 2012. — Vol. 70, № 11. — P. 1988-1994.

Kuo S.F., Chao T.C., Chang H.Y. et al. Prognostic evaluation of patients with multicentric papillary thyroid microcarcinoma // J. Form. Med. Assoc. — 2011. — Vol. 110, № 8. — P. 511-517.

Latrofa F., Ricci D., Montanelli L. et al. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin // Clin. Endocrinol. Metab. — 2012. — Vol. 97, № 7. — P. 2380-2387.

Lee J., Nam K.H., Chung W.Y. et al. Clinicopathologic features and treatment outcomes in differentiated thyroid carcinoma patients with concurrent Graves' disease // J. Korean Med. Sci. — 2008. — Vol. 23. — P. 796-801.

Lin J.D., Chao T.C., Hsueh C., Kuo S.F. High recurrent rate of multicentric papillary thyroid carcinoma // Ann. Surg. Oncol. — 2009. — Vol. 16, № 9. — P. 2609-2616.

LiVolsy V.A. Surgical Pathology of Thyroid. — Philadelphia: Saunders, 1990. — 422 p.

LiVolsi V.A., Abrosimov A.A., Bogdanova T.I. et al. The Chernobyl thyroid cancer experience: pathology // Clin. Oncology. — 2011. — Vol. 23, № 4. — P. 261-267.

Lo C.Y., Chan W.F., Lang B.H. et al. Papillary microcarcinoma: is there any difference between clinically overt and occult tumors? // World J. Surg. — 2006. — Vol. 30, № 5. — P. 759-766.

Londero S.C., Krogdahl A., Bastholt L. et al. Papillary thyroid microcarcinoma in Denmark 1996–2008: A national study of epidemiology and clinical significance // Thyroid. — 2013. — Vol. 21, № 1. — P. 117-124.

Lundgren C., Hall P., Dickman P. et al. Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer // Br. J. Surg. — 2007. — Vol. 94. — P. 571-577.

Luo J., McManus C., Chen H., Sippel R.S. Are there predictors of malignancy in patients with multinodular goiter? // J. Surg. Res. — 2012. — Vol. 174, № 2. — P. 207-210.

Marrazzo A., Taormina P., David M. Thyroid carcinoma: from diagnosis to therapy // Chir. Ital. — 2008. — Vol. 3, № 5. — P. 685-695.

Mazeh H., Samet Y., Hochstein D. et al. Multifocality in well-differentiated thyroid carcinomas calls for total thyroidectomy // Am. J. Surg. — 2010. — Vol. 22. — P. 38-42.

Mazzaferri E.L. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients / E.L. Mazzaferri, R.L. Young // Am. J. Med. — 1981. — Vol. 70, № 3. — P. 511-518.

McNally R.J., Blakey K., James P.W. et al. Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis // Еur. J. Epidemiol. — 2012. — Vol. 27, № 8. — P. 615-622.

Mehanna R., Murphy M., McCarthy J. et al. False negatives in thyroid cytology: Impact of large nodule size and follicular variant of papillary carcinoma // Laryngoscope. — 2013. — Vol. 123, № 5. — P. 1305-1309.

Morris L.F., Waguespack S.G., Warneke C.L. et al. Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy // Surg. — 2012. — Vol. 152, № 6. — P. 1165-1171.

Nakashima T., Nakashima A., Murakami D. et al. Follicular carcinoma of the thyroid with massive invasion into the cervical and mediastinum great veins: our own experience and literature review // Laryngoscope. — 2012. — Vol. 122, № 12. — P. 2855-2877.

Neuhold N., Schultheis A., Hermann M. et al. Incidental papillary microcarcinoma of the thyroid — further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up // Ann. Surg. Oncol. — 2011. — Vol. 18, № 12. — P. 3430-3436.

Nilubol N., Zhang L., Kebebew E. Multivariate analysis of the relationship between male gender, disease specific survival and features of tumor aggressiveness in thyroid cancer of follicular cell origin // Thyroid. — 2012. — (in press on-line).

Oertli D., Harder F. Surgical approach to thyroid nodules and cancer // Best. Pract. Res. Clin. Endocrinol. Metab. — 2000. — Vol. 14, № 4. — P. 651-666.

Okere P.C., Olusina D.B., Shamim S.A. et al. Pattern of second primary malignancies in thyroid cancer patients // Niger. J. Clin. Pract. — 2013. — Vol. 16, № 1. — P. 96-99.

Pacini F. Thyroid microcarcinoma // Best. Pract. Res. Clin. Endocrinol. Metab. — 2012. — Vol. 26, № 3. — P. 381-389.

Pacini F., Schlumberger M., Dralle H. et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium // Eur. J. Endocrinol. — 2006. — Vol. 154, № 6. — P. 787-803.

Page C., Biet A., Zaatar R. et al. Management of the papillary microcarcinoma of the thyroid gland // J. Otolaryngol. Head Neck Surg. — 2008. — Vol. 37, № 5. — P. 649-656.

Palestrini N., Borasi A., Cestino L. et al. Is central dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience // Langenbecks Arch. Surg. — 2008. — Vol. 393. — P. 693-698.

Pazaitou-Panayiotou K., Perros P., Boudina M. et al. Mortality from thyroid cancer in patients with hyperthyroidism: the theagenion cancer hospital experience // Eur. J. Endocrinol. — 2008. — Vol. 159. — P. 799-803.

Pelizzo M.R., Boschin I.M., Toniato A. et al. Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a monoinstitutional 12-year experience // Nucl. Med. Commun. — 2004. — Vol. 25. — P. 547-552.

Piana S., Frasoldati A., Di Felice E. et al. Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma // Am. J. Surg. Pathol. — 2010. — Vol. 34, № 6. — P. 868-872.

Piana S., Ragazzi M., Tallini G. et al. Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: Report of 3 cases, with morphological and molecular analysis // Hum. Pathol. — 2013. — Vol. 44, № 4. — P. 556-565.

Pisanu A., Deplano D., Reccia I. et al. Encapsulated papillary thyroid carcinoma: is it a distinctive clinical entity with low grade malignancy? // J. Endocrinol. Invest. — 2013. — Vol. 36, № 2. — P. 78-83.

Pitoia F., Cavallo A. Cancer de tiroides en busqueda del trattamento individualizando // Medicina. — 2012. — Vol. 72. — P. 503-513.

Pradeep P.V., Ragavan M., Ramakrishna B.A. et al. Surgery in Hashimoto’s thyroiditis: indications, complications, and associated cancers // Postgrad. Med. — 2011. — Vol. 57, № 2. — P. 120-122.

Pradhan G.B., Shrestha R., Shrestha S. et al. The incidence of thyroid carcinoma in multinodular goiter: prospective study // Nepal. Med. Coll. J. — 2011. — Vol. 13, № 3. — P. 169-171.

Rahbar K., Hutzenlaub V., Fischer R.J. et al. Risk-profile and outcome of small papillary and follicular thyroid carcinomas (< or = 1 cm) // Nukl. Med. — 2008. — Vol. 47, № 5. — P. 188-193.

Rahmani N., Abbas Hashemi S., Fazli M., Raisian M. Clinical management and outcomes of papillary, follicular and medullary thyroid cancer surgery // Med. Glas. (Zenica). — 2013. — Vol. 1. — P. 164-167.

Reiners Ch. Radio-iodine therapy in differentiated thyroid cancer: indications and procedures // Best. Pract. Res. — 2008. — Vol. 22, № 6. — P. 989-1007.

Rivera M., Tuttle R.M., Patel S. et al. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern)// Thyroid. — 2009. — Vol. 19, № 2. — P. 119-127.

Rizzo M., Sindoni A., Talamo Rossi R. et al. Annual increase in the frequency of papillary thyroid carcinoma as diagnosed by fine-needle aspiration at a cytology unit in Sicily // Hormones (Athens). — 2013. — Vol. 12, № 1. — P. 46-57.

Romanchischen A.F., Gostimskii A.V., Kuznetsova Iu.V. Inadequate operations for carcinoma of the thyroid gland // Vestn. Khir. — 2012. — Vol. 171, № 4. — P. 55-57.

Ron E., Brenner A. Non-malignant thyroid diseases after a wide range of radiation exposures // Radiat. Res. — 2010. — Vol. 174, № 6. — P. 877-888.

Rosai J., Cargangiu M.L., Dellelis R.A. Tumors of the Thyroid Gland. — Washington, D.C.: Armed Forces Institute of Pathology, 1992. — 343 p.

Samaan N.A., Schultz P.N., Ordones N.G. A comparison of thyroid carcinoma in those who have and have not had head and neck irradiation in childhood // J. Clin. Endocrinol. Metabol. — 1987. — V. 64, № 2. — P. 219-223.

Seningen J.L., Nassar A., Henry M.R. Correlation of thyroid nodule fine-needle aspiration cytology with corresponding histology at Mayo Clinic, 2001–2007: an institutional experience of 1,945 cases // Diagn. Cytopathol. — 2012. — Vol. 40. — P. 27-32.

Shen Y., Ruan M., Luo Q. et al. Brain metastasis from follicular thyroid carcinoma: treatment with sorafenib // Thyroid. — 2012. — Vol. 22, № 8. — P. 856-860.

Shu X., Ji J., Li X. et al. Cancer risk in patients hospitalised for Graves’ disease: a population-based cohort study in Sweden // Br. J. Cancer. — 2010. — Vol. 102, № 9. — P. 1397-1399.

Sıklar Z., Berberoglu M., Yagmurlu A. et al. Synchronous occurrence of papillary carcinoma in the thyroid gland and thyroglossal duct in an adolescent with congenital hypothyroidism // J. Clin. Res. Pediatr. Endocrinol. — 2012. — Vol. 4, № 1. — P. 30-33.

Smith J.J., Chen X., Schneider D.F. et al. Cancer after thyroidectomy: a multi-institutional experience with 1,523 patients // J. Am. Coll. Surg. — 2013. — Vol. 216, № 4. — P. 571-577.

Song H.J., Xue Y.L., Xu Y.H. et al. Rare metastases of differentiated thyroid carcinoma: pictorial review // Endocr. Relat. Cancer. — 2011. — Vol. 18, № 5. — P. R165-R174.

Soyder A., Unübol M., Sen O. et al. The predictive value of the clinical features of malignancy in cases of preoperative follicular thyroid neoplasia // Minerva Chir. — 2012. — Vol. 67, № 6. — P. 475-480.

Sugino K., Kameyama K., Ito K. et al. Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma // Thyroid. — 2012. — Vol. 8. — P. 798-804.

Sung J.Y., Na D.G., Kim K.S. et al. Diagnostic accuracy of fine-needle aspiration versus core-needle biopsy for the diagnosis of thyroid malignancy in a clinical cohort // Eur. Radiol. — 2012. — Vol. 22, № 7. — P. 1564-1572.

Sywak M., Cornford L., Roach P. et al. Routine ipsilateral level YI lymphadenoectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer // Surg. — 2006. — Vol. 140. — P. 1000-1005.

Torfs A., Laureyns G., Lemkens P. Outpatient hemithyroidectomy: safety and feasibility // B. Ent. — 2012. — Vol. 8, № 4. — P. 279-283.

Tronko M., Bogdanova T., Voskoboynyk L. et al. Radiation induced cancer: fundamental and applied aspects // Exp. Oncol. — 2010. — Vol. 32, № 3. — P. 200-204.

Uchino S., Noguchi S., Yamashita H. et al. Modified radical neck dissection for differentiated thyroid cancer: operative technique // World J. Surg. — 2004. — Vol. 28. — P. 1199-1203.

Uhry Z., Belot A., Colonna M. et al. National cancer incidence is estimated using the incidence/mortality ratio in countries with local incidence data: Is this estimation correct? // Cancer Epidemiol. — 2013. (on-line).

Ustün H., Astarcı H. M., Altunkaya C. et al. Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to thyroid Bethesda system // Acta Cytol. — 2012. — Vol. 56, № 4. — P. 361-369.

Vassiliou I., Tympa A., Arkadopoulos N. et al. Total thyroidectomy as the single surgical option for benign and malignant thyroid disease: a surgical challenge // Arch. Med. Sci. — 2013. — Vol. 9, № 1. — P. 74-78.

Venkat R., Guerro M.A. Recent advances in the surgical treatment of differentiated thyroid cancer: A comprehensive review // Sci. World J. — 2013. (on line).

Verburg F.A., Mäder U., Tanase K. et al. Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients // Clin. Endocrinol. Metab. — 2013. — Vol. 98, № 1. — P. 172-180.

Verburg F.A., Reiners C. The association between multinodular goiter and thyroid cancer // Minerva Endocrinol. — 2010. — Vol. 35, № 3. — P. 187-192.

White M., Gauger P., Doherty G. Central lymph node dissection in differentiated thyroid cancer // World J. Surg. — 2007. — Vol. 31. — P. 895-904.

Wojtczak B., Sutkowski K., Bolanowski M. et al. The prognostic value of fine-needle aspiration biopsy of the thyroid gland — analysis of results of 1078 patients // Neuro. Endocrinol. Lett. — 2012. — Vol. 33, № 5. — P. 511-516.

Xie W.C., Chan M.H., Mak K.C. et al. Trends in the incidence of 15 common cancers in Hong Kong, 1983–2008 // Asian Pac. J. Cancer Prev. — 2012. — Vol. 13, № 8. — P. 3911-3916.

Yalla N.M., Reynolds L.R. Hürthle cell thyroid carcinoma presenting as a «hot» nodule // Endocr. Pract. — 2011. — Vol. 17, № 3. — P. 68-72.

Yano Y., Shibuya H., Kitagawa W. et al. Recent outcome of Graves’ disease patients with papillary thyroid cancer // Eur. J. Endocrinol. — 2007. — Vol. 157, № 3. — P. 325-329.

Yu X.M., Lloyd R., Chen H. Current treatment of papillary thyroid microcarcinoma // Adv. Surg. — 2012. — Vol. 46. — P. 191-203.

Yu W-B., Song Y.T., Zang N.S. Completion lobectomy and central compartment dissection in low-risk patients who had undergone less extensive surgery // Oncol. Lett. — 2013. — Vol. 5. — P. 743-748.

Yuan L., Yang J. Radioiodine treatment in pediatric Graves’ disease and thyroid carcinoma // J. Pediatr. Endocrinol. Metab. — 2011. — Vol. 24, № 11-12. — P. 877-883.

Zerey M. Short-term outcomes after unilateral versus complete thyroidectomy for malignancy: a national perspective // Surg. — 2009. — Vol. 75, № 1. — P. 20-24.